Healthcare provider profile · identity verified

Dawn M. Wright, NP-C

Nurse Practitioner · BRADENTON, FL · NPI 1992803472

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	156
Lisinopril	Lisinopril	360	98
Albuterol Sulfate Hfa	Albuterol Sulfate	312	99
Levothyroxine Sodium	Levothyroxine Sodium	311	78
Gabapentin	Gabapentin	298	79
Fluticasone Propionate	Fluticasone Propionate	295	124
Amlodipine Besylate	Amlodipine Besylate	263	81
Metformin Hcl	Metformin Hcl	254	58
Rosuvastatin Calcium	Rosuvastatin Calcium	254	71
Losartan Potassium	Losartan Potassium	251	73
Pantoprazole Sodium	Pantoprazole Sodium	242	77
Sertraline Hcl	Sertraline Hcl	213	60
Metoprolol Succinate	Metoprolol Succinate	204	54
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	201	68
Diclofenac Sodium	Diclofenac Sodium	187	112
Clopidogrel	Clopidogrel Bisulfate	169	43
Metoprolol Tartrate	Metoprolol Tartrate	163	44
Trazodone Hcl	Trazodone Hcl	150	36
Omeprazole	Omeprazole	131	41
Glipizide	Glipizide	118	27
Eliquis	Apixaban	116	19
Carvedilol	Carvedilol	114	31
Alendronate Sodium	Alendronate Sodium	111	32
Montelukast Sodium	Montelukast Sodium	110	46
Azithromycin	Azithromycin	109	89
Furosemide	Furosemide	108	37
Prednisone	Prednisone	106	50
Duloxetine Hcl	Duloxetine Hcl	98	39
Tizanidine Hcl	Tizanidine Hcl	95	44
Hydrochlorothiazide	Hydrochlorothiazide	89	29
Isosorbide Mononitrate Er	Isosorbide Mononitrate	88	15
Mirtazapine	Mirtazapine	77	23
Warfarin Sodium	Warfarin Sodium	76	suppressed
Spironolactone	Spironolactone	75	15
Doxycycline Monohydrate	Doxycycline Monohydrate	73	56
Metformin Hcl Er	Metformin Hcl	73	18
Famotidine	Famotidine	67	19
Tamsulosin Hcl	Tamsulosin Hcl	66	24
Potassium Chloride	Potassium Chloride	63	25
Citalopram Hbr	Citalopram Hydrobromide	60	17
Levofloxacin	Levofloxacin	60	43
Ezetimibe	Ezetimibe	57	15
Valsartan	Valsartan	56	15
Simvastatin	Simvastatin	41	13
Bumetanide	Bumetanide	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	12
Oxybutynin Chloride Er	Oxybutynin Chloride	38	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Nifedipine Er	Nifedipine	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Methylprednisolone	Methylprednisolone	35	31
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Bupropion Xl	Bupropion Hcl	32	suppressed
Calcitriol	Calcitriol	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	22
Alprazolam	Alprazolam	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Amoxicillin	Amoxicillin	25	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	16
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	19
Jardiance	Empagliflozin	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Digoxin	Digoxin	20	suppressed
Fluconazole	Fluconazole	20	11
Glipizide Er	Glipizide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Baclofen	Baclofen	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	12
Ondansetron Odt	Ondansetron	17	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	17	13
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Novolin N	Insulin Nph Human Isophane	16	suppressed
Ozempic	Semaglutide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Primidone	Primidone	15	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Torsemide	Torsemide	13	suppressed
Atenolol	Atenolol	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	11
Ranolazine Er	Ranolazine	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Benzonatate	Benzonatate	11	suppressed
Lactulose	Lactulose	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error